The Symani Restore Study

计划入组 15 人 · 首次发布于 2025 年 8 月 26 日

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

计划入组 455 人 · 首次发布于 2024 年 12 月 9 日

CONNECT: A Multi-Cohort, Prospective Investigation of the Symani® Surgical System

计划入组 180 人 · 首次发布于 2025 年 3 月 10 日

NaV1.7 inhibitor (injectable depot, surgical pain)

C213 Microneedle System

drug delivery system

ACTIV SURGICAL

India

QUANTUM SURGICAL

France

Prescient Surgical, Inc.

United States

FDA Clears MMI to Expand Enrollment in Pioneering Robotic Microsurgery Trial for Alzheimer's Disease

MMI Launches Largest U.S. Clinical Trial for Robotic Microsurgery with First Patient Enrollment

MMI Achieves Major Milestones with FDA Clearance for Robotic Microsurgical Instruments and New CPT Reimbursement Code